Removal of Pharmaceuticals from Secondary Effluents by an Electro-Peroxone Process.

Weikun Yao,Xiaofeng Wang,Hongwei Yang,Gang Yu,Shubo Deng,Jun Huang,Bin Wang,Yujue Wang
DOI: https://doi.org/10.1016/j.watres.2015.11.024
IF: 12.8
2016-01-01
Water Research
Abstract:This study compared the removal of pharmaceuticals from secondary effluents of wastewater treatment plants (WWTPs) by conventional ozonation and the electro-peroxone (E-peroxone) process, which involves electrochemically generating H2O2 in-situ from O-2 in sparged O-2 and O-3 gas mixture (i.e., ozone generator effluent) during ozonation. Several pharmaceuticals with k(O3) ranging from <0.1 to 6.8 x 10(5) M-1 s(-1) were spiked into four secondary effluents collected from different WWTPs, and then treated by ozonation and the E-peroxone process. Results show that both processes can rapidly remove ozone reactive pharmaceuticals (diclofenac and gemfibrozil), while the E-peroxone process can considerably accelerate the removal of ozone-refractory pharmaceuticals (e.g., ibuprofen and clofibric acid) via indirect oxidation with (OH)-O-center dot generated from the reaction of sparged O-3 with electro-generated H2O2. Compared with ozonation, the E-peroxone process enhanced the removal kinetics of ozone-refractory pharmaceuticals in the four secondary effluents by similar to 40-170%, and the enhancement was more pronounced in secondary effluents that had relatively lower effluent organic matter (EfOM). Due to its higher efficiency for removing ozone-refractory pharmaceuticals, the E-peroxone process reduced the reaction time and electrical energy consumption required to remove >= 90% of all spiked pharmaceuticals from the secondary effluents as compared to ozonation. These results indicate that the E-peroxone process may provide a simple and effective way to improve existing ozonation system for pharmaceutical removal from secondary effluents. (C) 2015 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?